In a 28-year-old gravida 2 para 1 woman at 14 weeks gestation presenting with dysuria, fever, right costovertebral angle tenderness and a urine analysis showing bacteriuria and pyuria, what is the appropriate next step in management?

Management of Suspected Pyelonephritis in a Pregnant Patient at 14 Weeks Gestation

Admit the patient for IV ceftriaxone. Pregnant women with pyelonephritis require hospitalization and initial parenteral antibiotic therapy because they face significantly elevated risk of severe maternal and fetal complications, including preterm labor, sepsis, ARDS, transient renal failure, and hematologic abnormalities. 1, 2, 3, 4, 5, 6

---

Rationale for Admission and Parenteral Therapy

• Pregnancy is a high-risk condition for pyelonephritis complications: Up to 20–25% of pregnant women with untreated bacteriuria progress to acute pyelonephritis, and those who develop pyelonephritis experience serious complications—including septic shock syndrome, renal dysfunction, hemolysis, thrombocytopenia, and pulmonary capillary injury—in approximately 20% of cases. 3, 6

• Hospitalization is the standard of care: All major guidelines and clinical reviews recommend inpatient management for pregnant women with pyelonephritis, regardless of trimester, because of the unpredictable risk of rapid clinical deterioration and the need for close maternal-fetal monitoring. 4, 5, 6

• Parenteral antibiotics are required initially: IV therapy ensures adequate drug levels, bypasses gastrointestinal absorption issues (nausea/vomiting are common in pyelonephritis), and allows rapid adjustment if the patient deteriorates. 4, 5, 6

---

Why the Other Options Are Inappropriate

Option A: Discharge on oral cephalexin

• Oral monotherapy is inadequate for pyelonephritis in pregnancy because it does not provide the rapid, high serum concentrations needed to treat upper urinary tract infection in a high-risk host. 4, 5
• Outpatient management is appropriate only for uncomplicated cystitis or, in rare cases, very early pyelonephritis in the first trimester with close follow-up—but this patient has established pyelonephritis (fever, flank pain, CVA tenderness, bacteriuria, pyuria) at 14 weeks, which mandates admission. 4, 5

Option B: Obtain bilateral renal ultrasound

• Imaging is not indicated for uncomplicated acute pyelonephritis, even in pregnancy. 1
• Ultrasound should be reserved for patients who remain febrile after 72 hours of appropriate antibiotic therapy or who show clinical deterioration, as these findings suggest obstruction, abscess, or stone disease. 1, 2
• Ordering imaging before initiating treatment delays necessary antibiotics and does not change initial management in an uncomplicated case. 1, 2

Option C: Discharge on oral antibiotics following a single IV dose of ceftriaxone

• A single IV dose followed by oral therapy is appropriate for non-pregnant adults with uncomplicated pyelonephritis who can tolerate oral intake and have no high-risk features. 5
• Pregnancy itself is a high-risk feature that mandates hospitalization and continued parenteral therapy until the patient is afebrile for 24–48 hours and clinically stable. 4, 5, 6
• Approximately 25% of pregnant women with bacteriuria develop pyelonephritis if untreated, and those with pyelonephritis have a one-third recurrence rate even after treatment, underscoring the need for inpatient monitoring. 3, 6

---

Recommended Inpatient Management Protocol

1. Immediate Actions Upon Admission

• Obtain urine culture with antimicrobial susceptibility testing before starting antibiotics to guide targeted therapy once results are available. 1, 2, 5
• Initiate IV ceftriaxone 1–2 g once daily as the preferred first-line parenteral agent for hospitalized patients with pyelonephritis; ceftriaxone provides excellent coverage of common uropathogens (including E. coli, Klebsiella, Proteus) and is safe in pregnancy. 1, 2, 7, 4, 5
• Administer IV fluids to maintain adequate hydration and renal perfusion, as pregnant women with pyelonephritis are at risk for transient renal dysfunction. 4, 6

2. Monitoring and Expected Clinical Response

• Reassess clinical status every 24 hours: Approximately 85–90% of pregnant women with pyelonephritis respond within 48–72 hours to IV fluids and antibiotics, becoming afebrile and showing symptomatic improvement. 5, 6
• If fever persists beyond 72 hours or the patient deteriorates clinically, obtain renal ultrasound or CT (with appropriate fetal shielding) to evaluate for obstruction, abscess, or nephrolithiasis. 1, 2, 6
• Monitor for complications: Watch for signs of septic shock (hypotension, tachycardia, altered mental status), preterm labor (contractions, cervical change), renal dysfunction (rising creatinine, oliguria), hemolysis, thrombocytopenia, or pulmonary symptoms (dyspnea, hypoxia suggesting ARDS). 3, 4, 6

3. Transition to Oral Therapy

• Once the patient is afebrile for 24–48 hours and tolerating oral intake, transition to an oral antibiotic guided by culture susceptibility results. 4, 5
• Appropriate oral options include:
  • Cephalexin 500 mg four times daily
  • Amoxicillin-clavulanate 875/125 mg twice daily
  • Nitrofurantoin 100 mg twice daily (avoid after 36 weeks gestation due to risk of neonatal hemolysis)
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily (avoid in the first trimester and after 32 weeks due to teratogenic and neonatal kernicterus risks) 4, 5

4. Total Duration of Therapy

• Complete a 7–14 day total course of antibiotics (IV plus oral), with most patients requiring 10–14 days given the high recurrence rate in pregnancy. 1, 2, 4, 5

5. Post-Treatment Follow-Up

• Obtain a repeat urine culture 1–2 weeks after completing therapy to document microbiologic cure, as recurrence occurs in approximately one-third of pregnant women treated for pyelonephritis. 3, 6, 8
• Perform monthly urine cultures for the remainder of the pregnancy to detect recurrent bacteriuria early, as untreated recurrence carries a 25% risk of repeat pyelonephritis. 3, 6, 8
• If bacteriuria recurs, treat promptly and consider suppressive antibiotic therapy (e.g., nitrofurantoin 100 mg daily at bedtime) for the remainder of pregnancy. 3, 6

---

Common Pitfalls to Avoid

• Do not attempt outpatient management of pyelonephritis in pregnancy: The risk of rapid deterioration and serious maternal-fetal complications mandates hospitalization. 4, 5, 6
• Do not delay antibiotics to obtain imaging: Imaging is not indicated initially and should be reserved for patients who fail to respond to appropriate therapy within 72 hours. 1, 2
• Do not rely on a single IV dose followed by oral therapy: Pregnant women require continued parenteral antibiotics until clinically stable and afebrile for at least 24–48 hours. 4, 5, 6
• Do not assume treatment is complete after clinical resolution: Recurrence rates are high (up to one-third), and close follow-up with repeat cultures is essential to prevent repeat episodes. 3, 6, 8
• Do not forget to screen for bacteriuria at the first prenatal visit: Routine screening and treatment of asymptomatic bacteriuria in pregnancy prevents up to 75% of pyelonephritis cases. 9, 3, 8